Embedding Your Drug Strategy Within a Solid Foundation for Success
Demand for drugs and therapeutics is growing thanks to the globalization of pharmaceutical-based medicine. Manufacturing new drugs and getting them to market faster, more economically and safely demands development strategies and business models that support successful outcomes for both investors and patients.
Outsourcing has become an increasingly attractive business model for pharma as companies seek partners who can deliver comprehensive end-to-end drug substance and drug product development. It has prompted contract manufacturing organizations (CMOs) to consolidate and expand to create more comprehensive contract development and manufacturing organization (CDMO). Since then, the CDMO model has evolved and a new class of CDMO has emerged; the embedded CDMO.
Download to find out more.